Background: Nanoparticle pharmacokinetics and biological effects are influenced by several factors. We assessed the effects of amorphous SiO2 coating on the pharmacokinetics of zinc oxide nanoparticles (ZnO NPs) following intratracheal (IT) instillation and gavage in rats.
Methods: Uncoated and SiO2-coated ZnO NPs were neutron-activated and IT-instilled at 1 mg/kg or gavaged at 5 mg/kg. Rats were followed over 28 days post-IT, and over 7 days post-gavage. Tissue samples were analyzed for 65Zn radioactivity. Pulmonary responses to instilled NPs were also evaluated at 24 hours.
Results: SiO2-coated ZnO elicited significantly higher inflammatory responses than uncoated NPs. Pulmonary clearance of both 65ZnO NPs was biphasic with a rapid initial t1/2 (0.2 - 0.3 hours), and a slower terminal t1/2 of 1.2 days (SiO2-coated ZnO) and 1.7 days (ZnO). Both NPs were almost completely cleared by day 7 (>98%). With IT-instilled 65ZnO NPs, significantly more 65Zn was found in skeletal muscle, liver, skin, kidneys, cecum and blood on day 2 in uncoated than SiO2-coated NPs. By 28 days, extrapulmonary levels of 65Zn from both NPs significantly decreased. However, 65Zn levels in skeletal muscle, skin and blood remained higher from uncoated NPs. Interestingly, 65Zn levels in bone marrow and thoracic lymph nodes were higher from coated 65ZnO NPs. More 65Zn was excreted in the urine from rats instilled with SiO2-coated 65ZnO NPs. After 7 days post-gavage, only 7.4% (uncoated) and 6.7% (coated) of 65Zn dose were measured in all tissues combined. As with instilled NPs, after gavage significantly more 65Zn was measured in skeletal muscle from uncoated NPs and less in thoracic lymph nodes. More 65Zn was excreted in the urine and feces with coated than uncoated 65ZnO NPs. However, over 95% of the total dose of both NPs was eliminated in the feces by day 7.
Conclusions: Although SiO2-coated ZnO NPs were more inflammogenic, the overall lung clearance rate was not affected. However, SiO2 coating altered the tissue distribution of 65Zn in some extrapulmonary tissues. For both IT instillation and gavage administration, SiO2 coating enhanced transport of 65Zn to thoracic lymph nodes and decreased transport to the skeletal muscle.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237897 | PMC |
| http://dx.doi.org/10.1186/s12989-014-0044-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Zinc Accumulates in the Nodes of Wheat Following the Foliar Application of Zn Oxide Nano- and Microparticles.
Environ Sci Technol
October 2021
Future Industries Institute, University of South Australia, Mawson Lakes, SA 5095, Australia.
Using zinc (Zn) foliar fertilizers to enhance the grain quality of wheat () can be an effective alternative or supplement to Zn soil fertilizers. However, knowledge about the mechanisms of Zn absorption and translocation following foliar application is scarce. Here, autoradiography and γ-spectrometry were used to investigate the behavior of Zn applied to wheat leaves as soluble Zn chloride (ZnCl), chelated Zn (ZnEDTA), Zn oxide nanoparticle (ZnO-NP) suspensions, and ZnO microparticle (ZnO-MP) suspensions.
View Article and Find Full Text PDFSurface modification of zinc oxide nanoparticles with amorphous silica alters their fate in the circulation.
Nanotoxicology
August 2016
a Department of Environmental Health , Harvard T. H. Chan School of Public Health, Molecular and Integrative Physiological Sciences Program and Center for Nanotechnology and Nanotoxicology, Boston , MA , USA.
Nanoparticle (NP) pharmacokinetics and biological effects are influenced by many factors, especially surface physicochemical properties. We assessed the effects of an amorphous silica coating on the fate of zinc after intravenous (IV) injection of neutron activated uncoated (65)ZnO or silica-coated (65)ZnO NPs in male Wistar Han rats. Groups of IV-injected rats were sequentially euthanized, and 18 tissues were collected and analyzed for (65)Zn radioactivity.
View Article and Find Full Text PDFPhysiologically based pharmacokinetic modeling of zinc oxide nanoparticles and zinc nitrate in mice.
Int J Nanomedicine
August 2016
National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
Article Synopsis
- Zinc oxide nanoparticles (ZnO NPs) are used in various applications, but their behavior in living organisms is not well understood, leading this study to create a pharmacokinetic model for their interactions in mice.
- The study estimated key parameters such as partition coefficients and elimination rates for different sizes of ZnO NPs and compared them to zinc nitrate, discovering that smaller ZnO NPs have a higher tendency to accumulate in tissues, especially the lungs.
- The findings suggest that after a certain period, ZnO NPs may decompose into zinc ions, indicating the need for careful consideration regarding the potential long-term exposure effects of smaller ZnO NPs.
Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles.
Part Fibre Toxicol
September 2014
Center for Nanotechnology and Nanotoxicology, Molecular and Integrative Physiological Sciences Program, Department of Environmental Health, School of Public Health, Harvard University, 665 Huntington Avenue, Boston 02115, MA, USA.
Background: Nanoparticle pharmacokinetics and biological effects are influenced by several factors. We assessed the effects of amorphous SiO2 coating on the pharmacokinetics of zinc oxide nanoparticles (ZnO NPs) following intratracheal (IT) instillation and gavage in rats.
Methods: Uncoated and SiO2-coated ZnO NPs were neutron-activated and IT-instilled at 1 mg/kg or gavaged at 5 mg/kg.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!